Shaun Bagai Discusses the RenovoRx Revolution
RenovoRx (NASDAQ: RNXT) is a California-based biopharmaceutical company using targeted chemotherapy to treat difficult-to-reach tumors. The company has had several opportunities in the past year to present at investor conferences and is in the process of developing a therapeutic platform that will help eliminate cancerous tumors more safely and accurately. Shaun Bagai, CEO of RenovoRx gives us a look at how the company came to be and what its future looks like as these developments advance.
Shaun Bagai Discusses the RenovoRx Revolution
RenovoRx has had several opportunities in the past year to present at investor conferences and is in the process of developing a therapeutic platform that will help eliminate cancerous tumors more safely and accurately. Shaun Bagai, CEO of RenovoRx gives us a look at how the company came to be and what its future looks like as these developments advance.